MedPath

ong term follow up and comparative study of fecal microbiota after vonoprazan and low-dose amoxicillin dual therapy or vonoprazan-based triple therapy for Helicobacter pylori infectio

Not Applicable
Conditions
Helicobacter pylori infection
Registration Number
JPRN-UMIN000040025
Lead Sponsor
Division of Gastroenterology and Hepatology, Department of Medicine,Nihon University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
43
Inclusion Criteria

Not provided

Exclusion Criteria

1. Lack of informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The changes of fecal microbiota between baselines and 1 year after the treatments.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath